Affiliation:
1. Rudolf Magnus Institute for Pharmacology, University of Utrecht, Vondellaan 6, 3521 GD Utrecht, The Netherlands
Abstract
Abstract
The aim of the study was to discover whether the dopamine agonist bromocriptine has a central or peripheral site of action on blood pressure. An intraperitoneal injection of bromocriptine (0·5 mg kg−1) induced a long-lasting decrease in blood pressure in conscious spontaneously hypertensive rats (SHR). This effect was blocked by peripheral pretreatment with haloperidol or domperidone, but not by central treatment with haloperidol. A central injection of bromocriptine had only minor effects on blood pressure. These results suggest that primarily peripheral, rather than central, mechanisms are involved in the hypotensive effects of bromocriptine.
Publisher
Oxford University Press (OUP)
Subject
Pharmaceutical Science,Pharmacology
Reference25 articles.
1. A simple technique for rapid implantation of a permanent cannula into the rat brain ventricular system;Brakkee;Lab. Anim. Sci.,1979
2. Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons;Corrodi;J. Pharm. Pharmacol.,1973
3. Blood pressure effects of dopamine and bromocriptine in conscious spontaneously hypertensive rats (SHR);De Jong;Br. J. Pharmacol.,1986
4. Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocryptine;Fuxe;Acta Endocr.,1978
5. Bromocriptine is a potent α-adrenoreceptor antagonist in the perfused mesenteric blood vessels of the rat;Gibson;J. Pharm. Pharmacol.,1978
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献